Main Session

Sep 29

EDU 32 - ASTRO/SNO Joint Session: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?

Updates in Systemic Therapies for IDH Mutated Grade 2 - 3 Gliomas

05:17pm - 05:32pm PT

Presenter(s)

Jennie Taylor, MD - UCSF, San Francisco, CA